MedTrace Logo

Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)

NCT01349946 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2016-04-14

No results posted yet for this study

Summary

Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution Study 2 (DEFUSE 2) is a multi-center pilot study to determine if cerebral perfusion imaging can help identify which patients, who are ineligible for intravenous tissue plasminogen activator (iv tPA) therapy or have failed iv tPA therapy, are most likely to benefit from an endovascular clot removal procedure.

Conditions

  • Cerebrovascular Accident

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • St. Luke's Medical Center

    collaborator OTHER

  • Queen's Medical Center

    collaborator OTHER

  • Swedish Health Services

    collaborator UNKNOWN

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • Gregory W Albers · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-09-30
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01349946 on ClinicalTrials.gov